Malignancy: Clinical Trials

5 trials for Malignancy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Unknown 5
Phase 23Unknown 3

Follow Malignancy: new trials by email Literature Review of Malignancy trials Research Report on Malignancy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Al18F-NOTA-FAPI - Malignancy
Phase 2 / Phase 3UnknownCancer Institute and Hospital, Chinese Academy of Medical Sciences5002023-01-082024-03-29
Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis
Apixaban, Enoxaparin - Deep Vein Thrombosis, Malignancy
Phase 3UnknownBeni-Suef University1002019-07-032020-07-08
Real-time Cancer Pain Assessment and Intervention
real-time monitoring and instruction of cancer pain, standard cancer pain care - Malignancy, Pain
Phase 2 / Phase 3UnknownSun Yat-sen University2002012-03-012015-08-27
Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
ramosetron, ondansetron - Cancer, Malignancy
Phase 3UnknownHallym University Medical Center3382011-06-012012-10-03
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Levofloxacin - Malignancy, Allogeneic Stem Cell Transplantation
Phase 2 / Phase 3UnknownCharite University, Berlin, Germany2007-11-30

Narrower conditions

Neoplasms (5)  ·  Cancer Pain (1)  ·  Pain (1)  ·  Venous Thrombosis (1)  ·  Vomiting (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Neurologic Manifestations (1)  ·  Signs and Symptoms, Digestive (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)

Interventions

Enoxaparin (1)  ·  Levofloxacin (1)  ·  Ondansetron (1)  ·  apixaban (1)  ·  ramosetron (1)

Sponsors

Beni-Suef University (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Charite University, Berlin, Germany (1)  ·  Hallym University Medical Center (1)  ·  Sun Yat-sen University (1)

Countries

China (2)  ·  Egypt (1)  ·  Germany (1)  ·  South Korea (1)

Top investigators

Igor Wolfgang Blau, Dr. (1)  ·  Li Zhang, professor (1)  ·  Mostafa E Mokadem (1)  ·  Rong Zheng, M.D. (1)  ·  Sangwon Shin, M.D. (1)

Results publications

PMID 10737280, PMID 10963635, PMID 12393647, PMID 22898071, PMID 23702623, PMID 23725876, PMID 26407753, PMID 26867832, PMID 28373761, PMID 30103252, PMID 30918939, PMID 31504429, PMID 31630479, PMID 33153401